Upadacitinib Impurity 90 | CAS 24241-18-7 - Request Quote
Upadacitinib Impurity 90
| SZ CAT No: | SZ-U005102 |
| CAS No | 24241-18-7 |
| Mol.F. | C4H3Br2N3 |
| Mol.Wt. | 252.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Upadacitinib Impurity 90 is chemically 3,5-Dibromopyrazin-2-amine. Upadacitinib Impurity 90 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 90 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 24241-18-7
Purchase 24241-18-7
Order 24241-18-7
Enquire 24241-18-7
price of 24241-18-7
24241-18-7 Supplier
24241-18-7 Manufacturer
24241-18-7 Exporter
buy high quality Upadacitinib Impurity 90
Purchase Upadacitinib Impurity 90
Upadacitinib Impurity 90 suppliers
Upadacitinib Impurity 90 manufacturers
Upadacitinib Impurity 90 price
Order Upadacitinib Impurity 90
Enquire Upadacitinib Impurity 90
Upadacitinib Impurity 90 cost
Upadacitinib Impurity 90 Supplier
Upadacitinib Impurity 90 Distributor
Upadacitinib Impurity 90 for Method Validation
Upadacitinib Reference Standard
Upadacitinib Impurity 90 for ANDA Filing
Upadacitinib Impurity 90 for Forced Degradation Studies
Upadacitinib Impurity 90 Identification Standards
Upadacitinib Impurity 90 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.